Infection prevention company Tristel plc (AIM: TSTL) announced on Monday that it has commercially launched 3T Pro, a premium tier of its 3T digital compliance platform, marking the first paid version of the platform as the company seeks to build recurring digital revenue alongside its infection prevention products.
Previously offered free of charge, the 3T platform supports healthcare providers with staff training management and compliance tracking. Developed by Tristel's in-house software team, 3T Pro adds enhanced asset tracking and lifecycle management, advanced dashboards, structured audit reporting and a scalable data architecture to support future integrations.
The launch introduces a three-tier structure comprising a free entry-level version, a mid-tier combining training management with device traceability, and the premium 3T Pro offering advanced customisation, workflows, reporting and audit readiness. Existing users of traceability features will receive transitional licensing arrangements, while the free entry-level tier will remain available to encourage broad adoption across the healthcare sector.
United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device
Natera Signatera gains PMDA approval in Japan for colorectal cancer testing
Getinge launches Fluobeam LS for fluorescence‑guided small‑incision surgery
Airiver Medical treats first chronic rhinosinusitis patient in Drug Coated Balloon clinical study
Galmed Pharmaceuticals to acquire Colospan for GI-focused platform development
Medtronic seeks expanded US approvals for Hugo robotic surgery system
Waters secures FDA clearance for BD BACTEC FXI Blood Culture System
MiniMed expands Abbott partnership for dual glucose-ketone diabetes sensors
ILC Dover adds Water for Injection (WFI) and custom chemical solutions to offerings
Merz Therapeutics and Kvvit sign exclusive agreement for INBRIJA in Greater China
Implantica submits final FDA response for RefluxStop PMA application
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AngioDynamics reports 24-month PRESERVE data showing durable NanoKnife outcomes in prostate cancer
Cepheid receives CE mark for IVDR‑compliant gastrointestinal PCR panel